EU opinion & policy debates - across languages | BlogActiv.eu

Archives for Health & Consumers

Genval, 24 April, 2016. – Disclaimer: These are the transcripts of an interview originally published on International Innovation (issue 163) in November 2014. The authentic version is available at the International Innovation website. How to improve the health status and life expectancy of Europe’s population while reducing health inequalities? Overview of my work as a… » read more

  Posted by EU ZMK's Diary

Genval, 16th April 2016 – Ironic. While there are – at least – three, “low hanging fruit” type policy proposal on the table for the European Commission to improve population health in the EU, we can only expect a 1 day conference on chronic diseases. Talk shaw or real action, this is the question. ‘Towards… » read more

  Posted by EU ZMK's Diary

Genval, 11th April 2016. – Because trade secret is so widely defined that it includes clinical trials data, and despite of vague exceptions, it can well affect clinical trials transparency which is key for patient safety and new drug development. There is no guarantuee that Pharmaceutical companies will not abuse it. Why are Trade Secrets… » read more

  Posted by EU ZMK's Diary

Genval, 4th April, 2016 – Yes, it would, because – strangely enough – this time the industry is asking for more regulation: public health and consumer protection NGOs are united with processed food industry giants on the ban of industrially produced trans fats. Since this is a strange alliance of organisations usually having conflicting (private… » read more

  Posted by EU ZMK's Diary

Genval, 30 March, 2016. – Disclaimer: This is the English translation of an interview made by Mihail Călin and originally published on 25 September 2015. The authentic Romanian version is available at the euro-health.ro News/Media website. The Transatlantic Trade and Investment Partnership (TTIP) between the United States and the EU are surrounded by fierce controversy… » read more

  Posted by EU ZMK's Diary

  Two studies came out (just in time for Pesticide Action Week) that question the cost to society of pesticides and other chemicals. The logic is simple: Chemicals cost societies billions of dollars, therefore removing them would save money. I am a little troubled by such a simplistic view – like any statistical analysis, you… » read more

  Posted by The Risk-Monger

  The last blog looked at ten reasons why glyphosate is the herbicide of the century. So why then, despite the overwhelming scientific evidence and clear environmental and social benefits, is this product on the verge of having its authorisation removed? The NGO activists and pro-organic lobbyists have led a formidable campaign that started a… » read more

  Posted by The Risk-Monger

The following is the first of a two-part blog looking at how a corrupt unethical campaign against an essential agricultural product is succeeding in the EU. This first part will look at why glyphosate is such a good product for farmers; the second part will demonstrate how environmental NGOs, activist scientists, organic lobbyists and IARC… » read more

  Posted by The Risk-Monger

While the Energy Community yesterday failed to consider more stringent air pollution rules for the Western Balkans, a new report quantifies the health costs of the region’s coal burning both within the region itself as well as in the neighbouring European Union. by Ioana Ciuta, cross-posted from the Bankwatch blog I often hear that countries… » read more

  Posted by Bankwatch

Guest blog post by Sebastian Emig, Director General of the European Snacks Association (ESA).   Last week the Netherlands EU Presidency organised a High Level Conference on Food Product Improvement and presented a “Roadmap for action” establishing the initial steps towards a more concerted action at European level. The European Snacks Association (ESA) is among… » read more

  Posted by The Guest Blog

Genval, 8th March 2016. – The European Parliament is about to vote tomorrow on a tobacco agreement between the EU and Philipp Morris International (PMI) and it is at least questionable that the EU’s intention is legal, ethical or politically correct. At the same bed with the ennemy? From a legal point of view, according… » read more

  Posted by EU ZMK's Diary

Guest blog post by Carlos Lines Millán, President of the European Idiopathic Pulmonary Fibrosis & Related Disorders Federation (EU-IPFF). Idiopathic Pulmonary Fibrosis (IPF) is a rare but devastating, irreversible and chronic disease affecting around 100,000 Europeans. The causes are unknown, no universal cure exists, it is only ever manageable and those seeking a lung transplant… » read more

  Posted by The Guest Blog

EurActiv Network